Kura Oncology reports darlifarnib plus cabozantinib shows activity in kidney cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Kura Oncology reports darlifarnib plus cabozantinib shows activity in kidney cancer
(NASDAQ: KURA) Delayed: 10.36 +0.43 (4.33%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.54    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 1,383,021